• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧激活的神经肽 Y/Y5 受体/ RhoA 通路触发尤因肉瘤的染色体不稳定性和骨转移。

Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.

机构信息

Department of Physiology and Biophysics, Georgetown University, Washington, DC, United States.

New York Genome Center, New York, NY, United States.

出版信息

Nat Commun. 2022 Apr 28;13(1):2323. doi: 10.1038/s41467-022-29898-x.

DOI:10.1038/s41467-022-29898-x
PMID:35484119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9051212/
Abstract

Adverse prognosis in Ewing sarcoma (ES) is associated with the presence of metastases, particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic link between these factors remains unknown. We demonstrate that in ES, tumor hypoxia selectively exacerbates bone metastasis. This process is triggered by hypoxia-induced stimulation of the neuropeptide Y (NPY)/Y5 receptor (Y5R) pathway, which leads to RhoA over-activation and cytokinesis failure. These mitotic defects result in the formation of polyploid ES cells, the progeny of which exhibit high CIN, an ability to invade and colonize bone, and a resistance to chemotherapy. Blocking Y5R in hypoxic ES tumors prevents polyploidization and bone metastasis. Our findings provide evidence for the role of the hypoxia-inducible NPY/Y5R/RhoA axis in promoting genomic changes and subsequent osseous dissemination in ES, and suggest that targeting this pathway may prevent CIN and disease progression in ES and other cancers rich in NPY and Y5R.

摘要

尤文肉瘤(ES)的不良预后与转移的存在有关,特别是在骨骼中,肿瘤缺氧和染色体不稳定性(CIN)。然而,这些因素之间的机制联系仍然未知。我们证明,在 ES 中,肿瘤缺氧选择性地加剧了骨转移。这个过程是由缺氧诱导的神经肽 Y(NPY)/Y5 受体(Y5R)途径的刺激引发的,导致 RhoA 过度激活和胞质分裂失败。这些有丝分裂缺陷导致多倍体 ES 细胞的形成,其后代表现出高 CIN、侵袭和定植骨骼的能力以及对化疗的耐药性。在缺氧 ES 肿瘤中阻断 Y5R 可防止多倍体形成和骨转移。我们的研究结果为缺氧诱导的 NPY/Y5R/RhoA 轴在促进 ES 中的基因组改变和随后的骨播散中的作用提供了证据,并表明靶向该途径可能预防 ES 和其他富含 NPY 和 Y5R 的癌症中的 CIN 和疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/625cf8fc0506/41467_2022_29898_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/57002496cf24/41467_2022_29898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/35b53e2946b0/41467_2022_29898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/3f1cb20a7ad6/41467_2022_29898_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/92f886d5ac82/41467_2022_29898_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/d4208d1ffd31/41467_2022_29898_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/7e4f0efa91b5/41467_2022_29898_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/3058ae66e35a/41467_2022_29898_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/09fe6a8be132/41467_2022_29898_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/9d5b8a7dfb37/41467_2022_29898_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/625cf8fc0506/41467_2022_29898_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/57002496cf24/41467_2022_29898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/35b53e2946b0/41467_2022_29898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/3f1cb20a7ad6/41467_2022_29898_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/92f886d5ac82/41467_2022_29898_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/d4208d1ffd31/41467_2022_29898_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/7e4f0efa91b5/41467_2022_29898_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/3058ae66e35a/41467_2022_29898_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/09fe6a8be132/41467_2022_29898_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/9d5b8a7dfb37/41467_2022_29898_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f14/9051212/625cf8fc0506/41467_2022_29898_Fig10_HTML.jpg

相似文献

1
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.缺氧激活的神经肽 Y/Y5 受体/ RhoA 通路触发尤因肉瘤的染色体不稳定性和骨转移。
Nat Commun. 2022 Apr 28;13(1):2323. doi: 10.1038/s41467-022-29898-x.
2
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.缺氧使尤因肉瘤中神经肽Y的活性从生长抑制作用转变为生长促进作用。
Oncotarget. 2013 Dec;4(12):2487-501. doi: 10.18632/oncotarget.1604.
3
High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.高神经肽Y释放与尤因肉瘤骨转移相关——位点特异性转移的体内模型
Oncotarget. 2015 Mar 30;6(9):7151-65. doi: 10.18632/oncotarget.3345.
4
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.尤因肉瘤患者的神经肽Y系统水平和二肽基肽酶活性——与肿瘤表型和生存的关联
Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11.
5
Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.神经肽 Y 和神经肽 Y Y5 受体相互作用恢复了衰老骨髓基质细胞受损的生长潜力。
Rejuvenation Res. 2011 Aug;14(4):393-403. doi: 10.1089/rej.2010.1129. Epub 2011 May 19.
6
Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.神经肽Y(NPY)在肿瘤生长和进展中的作用:儿科肿瘤学的经验教训
Neuropeptides. 2016 Feb;55:55-66. doi: 10.1016/j.npep.2015.10.005. Epub 2015 Oct 26.
7
Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.缺氧诱导因子依赖性神经肽 Y 受体 Y1 和 Y5 的表达使缺氧细胞对 NPY 刺激敏感。
J Biol Chem. 2022 Mar;298(3):101645. doi: 10.1016/j.jbc.2022.101645. Epub 2022 Jan 27.
8
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.神经肽Y/Y5受体通路通过激活RhoA刺激神经母细胞瘤细胞运动。
Front Cell Dev Biol. 2021 Feb 17;8:627090. doi: 10.3389/fcell.2020.627090. eCollection 2020.
9
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.神经肽 Y Y5 受体通过细胞外信号调节激酶信号通路和环腺苷酸抑制促进人乳腺癌细胞的生长。
Mol Cancer Res. 2010 Apr;8(4):604-14. doi: 10.1158/1541-7786.MCR-09-0301. Epub 2010 Mar 23.
10
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.神经肽Y受体Y5作为神经母细胞瘤中的一种可诱导的促生存因子:对肿瘤化疗耐药性的影响
Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18.

引用本文的文献

1
KC1036, a multi-kinase inhibitor with anti-angiogenic activity, can effectively suppress the tumor growth of Ewing sarcoma.KC1036是一种具有抗血管生成活性的多激酶抑制剂,可有效抑制尤因肉瘤的肿瘤生长。
Angiogenesis. 2025 Sep 18;28(4):50. doi: 10.1007/s10456-025-10008-6.
2
TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma.放疗期间抑制转化生长因子β可增强尤因肉瘤中的免疫细胞浸润并减少转移。
Cancer Res Commun. 2025 Aug 1;5(8):1441-1457. doi: 10.1158/2767-9764.CRC-24-0346. Epub 2025 Aug 8.
3
Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis.

本文引用的文献

1
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma.STAG2 缺失重编程致癌和发育程序,促进尤文肉瘤转移。
Cancer Cell. 2021 Jun 14;39(6):827-844.e10. doi: 10.1016/j.ccell.2021.05.007.
2
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.神经肽Y/Y5受体通路通过激活RhoA刺激神经母细胞瘤细胞运动。
Front Cell Dev Biol. 2021 Feb 17;8:627090. doi: 10.3389/fcell.2020.627090. eCollection 2020.
3
Molecular mechanisms and clinical management of cancer bone metastasis.
靶向CRISPR方法揭示了神经肽Y受体Y5在尤因肉瘤肺外转移中的关键作用。
Oncogene. 2025 Jul 17. doi: 10.1038/s41388-025-03493-y.
4
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI.胃饥饿素诱导的神经元神经肽Y促进低体重指数肺癌患者的脑转移。
Nat Commun. 2025 Jul 1;16(1):5608. doi: 10.1038/s41467-025-60730-4.
5
The neuroscience of cancer: Focus on neuropeptidergic systems.癌症神经科学:聚焦神经肽能系统。
Acta Pharm Sin B. 2025 May;15(5):2323-2350. doi: 10.1016/j.apsb.2025.03.025. Epub 2025 Mar 13.
6
Targeting metastasis in paediatric bone sarcomas.靶向治疗小儿骨肉瘤的转移
Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z.
7
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.靶向突变型p53依赖的胰腺癌中的NPY/NPY1R信号轴会损害转移。
Sci Adv. 2025 Mar 14;11(11):eadq4416. doi: 10.1126/sciadv.adq4416. Epub 2025 Mar 12.
8
Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution.尤因肉瘤肿瘤的单细胞RNA测序揭示了转录异质性和克隆进化。
Clin Cancer Res. 2025 May 15;31(10):2010-2023. doi: 10.1158/1078-0432.CCR-24-2040.
9
Neuropeptide Y in cancer-biological functions and potential clinical implications.癌症中的神经肽Y——生物学功能及潜在临床意义
Cancer Metastasis Rev. 2025 Jan 6;44(1):21. doi: 10.1007/s10555-024-10237-z.
10
A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma.一种在尤因肉瘤中具有预后价值的新型组蛋白乙酰化相关基因特征。
Discov Oncol. 2024 Dec 30;15(1):848. doi: 10.1007/s12672-024-01689-4.
癌症骨转移的分子机制与临床管理
Bone Res. 2020 Jul 29;8(1):30. doi: 10.1038/s41413-020-00105-1. eCollection 2020.
4
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.Y5 受体与神经肽 Y 之间的分子串扰驱动肝癌。
J Clin Invest. 2020 May 1;130(5):2509-2526. doi: 10.1172/JCI131919.
5
Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.Hippo 通路效应物 YAP1/TAZ 诱导 EWS-FLI1 拮抗基因特征,并与尤文肉瘤的疾病进展相关。
J Pathol. 2020 Apr;250(4):374-386. doi: 10.1002/path.5379. Epub 2020 Feb 4.
6
Multimodal Treatment in Pelvic Ewing Sarcoma: A Prognostic Factor Analysis.骨盆尤文肉瘤的多模式治疗:预后因素分析
Surg Technol Int. 2019 May 15;34:489-496.
7
CRISPResso2 provides accurate and rapid genome editing sequence analysis.CRISPResso2可提供准确且快速的基因组编辑序列分析。
Nat Biotechnol. 2019 Mar;37(3):224-226. doi: 10.1038/s41587-019-0032-3.
8
Molecular landmarks of tumor hypoxia across cancer types.肿瘤缺氧的分子标志物在各种癌症类型中。
Nat Genet. 2019 Feb;51(2):308-318. doi: 10.1038/s41588-018-0318-2. Epub 2019 Jan 14.
9
Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells.抑郁诱导的神经肽 Y 分泌通过招募髓样细胞促进前列腺癌生长。
Clin Cancer Res. 2019 Apr 15;25(8):2621-2632. doi: 10.1158/1078-0432.CCR-18-2912. Epub 2018 Nov 30.
10
Neuropeptide Y receptor interactions regulate its mitogenic activity.神经肽 Y 受体相互作用调节其有丝分裂活性。
Neuropeptides. 2019 Feb;73:11-24. doi: 10.1016/j.npep.2018.11.008. Epub 2018 Nov 27.